Analysts Set Bath & Body Works, Inc. (NYSE:BBWI) Price Target at $43.13

Shares of Bath & Body Works, Inc. (NYSE:BBWI) have received an average rating of “Moderate Buy” from the sixteen research firms that are presently covering the firm, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $43.13.

A number of research analysts have recently commented on BBWI shares. Piper Sandler cut their price objective on shares of Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a research report on Thursday, July 11th. BMO Capital Markets reaffirmed an “outperform” rating and set a $50.00 price objective (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. The Goldman Sachs Group cut their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. Robert W. Baird cut their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. Finally, Bank of America cut their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, August 29th.

Insiders Place Their Bets

In other news, CEO Gina Boswell acquired 6,000 shares of the firm’s stock in a transaction on Wednesday, October 9th. The shares were purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the completion of the purchase, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.27% of the company’s stock.

Institutional Trading of Bath & Body Works

Several large investors have recently added to or reduced their stakes in BBWI. Anomaly Capital Management LP bought a new stake in Bath & Body Works during the second quarter worth about $113,995,000. Lone Pine Capital LLC grew its stake in shares of Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after purchasing an additional 1,547,399 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Bath & Body Works by 4.2% during the first quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock valued at $1,370,458,000 after purchasing an additional 1,102,124 shares during the last quarter. Assenagon Asset Management S.A. grew its stake in shares of Bath & Body Works by 723.4% during the third quarter. Assenagon Asset Management S.A. now owns 1,167,554 shares of the company’s stock valued at $37,268,000 after purchasing an additional 1,025,757 shares during the last quarter. Finally, Interval Partners LP grew its stake in shares of Bath & Body Works by 230.0% during the second quarter. Interval Partners LP now owns 1,280,593 shares of the company’s stock valued at $50,007,000 after purchasing an additional 892,488 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $31.62 on Wednesday. The firm has a market cap of $6.93 billion, a price-to-earnings ratio of 7.66, a P/E/G ratio of 0.92 and a beta of 1.79. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The firm has a fifty day moving average price of $30.08 and a two-hundred day moving average price of $37.25.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, sell-side analysts expect that Bath & Body Works will post 3.18 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.53%. Bath & Body Works’s dividend payout ratio is 19.37%.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.